Advertisement

Topics

ALFRED E. TIEFENBACHER (GmbH & Co. KG) Company Profile

10:04 EDT 25th June 2018 | BioPortfolio

AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countries, the Italian based Recordati became the first principal to be represented exclusively in Germany by AET. Today AET has over 40 best-of-breed suppliers from 13 countries around the globe, from which we can offer top-quality products at highly competitive prices. This classic API business continues to be a cornerstone of our success.

Location

Van-der-Smissen-Straße 1
Hamburg
D - 22767
Germany

Contact

Phone: 49 (0) 40 - 44 18 09 - 0
Fax: 49 (0) 40 - 44 18 09 - 26
Email: info@TIEFENBACHER.com


News Articles [180 Associated News Articles listed on BioPortfolio]

New species in the North Sea

(Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research) Experts from the Alfred Wegener Institute and the universities of Oldenburg and Potsdam, Germany have confirmed the existence...

Alfred Blalock’s medical breakthroughs have been saving many lives

The year was 1925, and Alfred Blalock was already a failure at age 26. The born-and-raised Georgian earned a bachelor's degree from the University of Georgia in 1918, then a medical doctorate from Joh...

Creating Living Therapeutics at the Royal Prince Alfred Hospital

Cell and Molecular Therapies (CMT), Royal Prince Alfred Hospital are committed to the development of novel cell therapies and the subsequent improvement in survival and quality of life of patients who...

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Original-Research: CO.DON AG (von Sphene Capital GmbH): Buy

Original-Research: CO.DON AG - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu CO.DON AG Unternehmen: CO.DON AG ISIN: DE000A1K0227 Anlass der Studie: Update Report Empfehlung: Buy se...

Original-Research: Medigene AG (von EQUITS GmbH): Kaufen

Original-Research: Medigene AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu Medigene AG Unternehmen: Medigene AG ISIN: DE000A1X3W00 Anlass der Studie: Übernahme-Angebot Empfehlung: Kaufen Kursz...

PH-FIX Indikatorstäbchen pH 4,5-10 100 St MACHEREY-NAGEL GMBH & CO. KG

EUR 10,24Angebotsende: Samstag Apr-7-2018 11:22:08 CESTSofort-Kaufen für nur: EUR 10,24Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : PH-FIX Indikatorstäbchen pH 4,...

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

Editorial: translation of the 1955 monograph by Alfred Bangerter on the treatment of amblyopia.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Clinical Trials [53 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

HIV-HBV Co-Infection and Liver Disease

Human immunodeficiency virus/Hepatitis B virus (HIV/HBV) co-infections are frequently observed due to shared routes of transmission, with reported figures indicating 6-9% of HIV-infected i...

Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord Injury

The primary aims of this study are to determine the safety of the RFM System (Alfred Mann Foundation, Santa Clarita, CA) in a patient with incomplete SCI and the effect of the RFM system o...

Companies [559 Associated Companies listed on BioPortfolio]

ALFRED E. TIEFENBACHER (GmbH & Co. KG)

AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countri...

Bioness, Inc.

Bioness, Inc. was established in 2004 by three of the world’s leaders in medical technology: the Alfred E. Mann Foundation for Scientific Research, Alfred E. Mann, and NESS Ltd. The Foundation is a ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Bio-Rad Laboratories

Nil

More Information about "ALFRED E. TIEFENBACHER (GmbH & Co. KG)" on BioPortfolio

We have published hundreds of ALFRED E. TIEFENBACHER (GmbH & Co. KG) news stories on BioPortfolio along with dozens of ALFRED E. TIEFENBACHER (GmbH & Co. KG) Clinical Trials and PubMed Articles about ALFRED E. TIEFENBACHER (GmbH & Co. KG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALFRED E. TIEFENBACHER (GmbH & Co. KG) Companies in our database. You can also find out about relevant ALFRED E. TIEFENBACHER (GmbH & Co. KG) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record